Nationwide shortage of ADHD drug Adderall is real

Beginning in late summer time, some folks raised alarms a couple of potential nationwide shortage of Adderall, a stimulant remedy generally used to deal with attention-deficit/hyperactivity dysfunction, generally referred to as ADHD.

“If you take this medication I’d recommend you talk to your doctor ASAP,” mentioned one physician in a warning about the Adderall shortage on Twitter. “There is no release date as of right now meaning we don’t know when it’ll be back in stock.”

Is there a nationwide shortage of Adderall?

Yes, there is a nationwide shortage of Adderall. This contains generic variations of the drug.

Sign up for the VERIFY Fast Facts day by day Newsletter!

Both the Food and Drug Administration (FDA) and the American Society of Health-System Pharmacists (ASHP) report a nationwide shortage of blended amphetamine salts, generally referred to by the model identify Adderall, on their separate drug shortage databases.

The FDA announced a nationwide Adderall shortage on Oct. 12, saying it was restricted to the immediate-release formulation of the name-brand drug and its generic variations. ASHP, which uses different criteria from the FDA for figuring out a drug shortage, says the shortage has been ongoing since July 27, 2022, for immediate-release formulations of Adderall and since Aug. 24, 2022, for the longer-lasting, extended-release formulation.

“The current shortage of amphetamine salts is due to manufacturing delays by one of the larger manufacturers of the product,” an ASHP spokesperson mentioned. “Other manufacturers are unable to make enough supply to keep up with demand.”

MORE FROM VERIFY: Posts on-line declare the US is shopping for a radiation illness drug. That’s true.

The FDA clarified the producer experiencing delays is Teva Pharmaceuticals, which produces each brand-name Adderall and generic variations of the drug. Teva, the biggest provider of Adderall within the U.S., informed NBC News again in August {that a} labor shortage on its packaging line was responsible for delays in delivering orders to some pharmacies.

This shortage follows one other Adderall shortage that started in 2019 and resulted in spring 2022, in response to the FDA and ASHP. “We received a lot of shortage reports from patients during the shortage earlier this year, but we are receiving many more reports from patients about the current shortage, so it appears to be worse,” the ASHP spokesperson mentioned.

Back in August, the National Community Pharmacists Association (NCPA) mentioned that 64% of surveyed group pharmacies had bother getting ahold of Adderall this 12 months.

Teva might stay behind on fulfilling demand till December 2022, in response to the FDA.

“Teva has active supply of both branded Adderall and its generic version and continues to produce and refill the channel regularly at levels above historical demand,” a Teva spokesperson informed VERIFY in an emailed assertion. “It is possible that some people may encounter a backorder (intermittently) based on timing and demand, but these are only temporary. We are actively shipping both branded and generic Adderall to customers, and we expect inventory recovery in the coming months.”

Even with the manufacturing delays and labor points, the FDA says Teva has been producing a bigger provide of Adderall than it might usually anticipate to “due to increased market demand.” According to well being analysis firm Trilliant Health, Adderall prescriptions nationwide have elevated since earlier than the COVID-19 pandemic started. This development is pushed totally by a pointy enhance in prescriptions for adults.

The FDA mentioned that sufferers who take Adderall ought to discuss to their physician about different remedy choices if they’ve problem getting their remedy.

More from VERIFY: No, you shouldn’t use hydrogen peroxide on wounds